Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Anorexia 5Neoplasms 4Weight Loss 2Pancreatic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Cachexia 2Breast Neoplasms 2Sleep Initiation and Maintenance Disorders 1Neoplasm Metastasis 1Malnutrition 1Lung Neoplasms 1Head and Neck Neoplasms 1Depressive Disorder, Major 1Depression 1Body Weight 1Anorexia Nervosa with Significantly Low Body Weight 1Advanced Cancer 1

Interventions

Therapeutics 29Psychiatric Rehabilitation 20Cognitive Behavioral Therapy 12Early Intervention, Educational 10Psilocybin 9Ketamine 9Methods 8Saline Solution 7Yoga 6Surveys and Questionnaires 6Mindfulness-Based Cognitive Therapy 6Esketamine 6Counseling 6Psychosocial Intervention 5Mindfulness 5Methylphenidate 5Educational Status 5Behavior Therapy 5Acupuncture Therapy 5Interviews as Topic 4Exercise Therapy 4Exercise 4Escitalopram 4Control Groups 4Caregivers 4Psychotherapy 3Palliative Care 3Niacin 3Mindfulness-Based Stress Reduction 3Melatonin 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Depression × Mirtazapine × Clear all
NCT02650544 2016-01-08

Efficacy and Safety Analyses of Mirtazapine in NSCLC Patients With Depression

Sun Yat-sen University

Phase 2 Unknown
236 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Depression

Data powered by HemOnc (CC BY 4.0) Colophon âš¡